247 related articles for article (PubMed ID: 25040885)
1. Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.
Olar A; Wani KM; Sulman EP; Mansouri A; Zadeh G; Wilson CD; DeMonte F; Fuller GN; Aldape KD
Brain Pathol; 2015 May; 25(3):266-75. PubMed ID: 25040885
[TBL] [Abstract][Full Text] [Related]
2. Phosphohistone H3 (PHH3) as a surrogate of mitotic figure count for grading in meningiomas: a comparison of PHH3 (S10) versus PHH3 (S28) antibodies.
Puripat N; Loharamtaweethong K
Virchows Arch; 2019 Jan; 474(1):87-96. PubMed ID: 30267302
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.
Fukushima S; Terasaki M; Sakata K; Miyagi N; Kato S; Sugita Y; Shigemori M
Brain Tumor Pathol; 2009; 26(2):51-7. PubMed ID: 19856215
[TBL] [Abstract][Full Text] [Related]
4. Phosphohistone-H3 Proliferation Index Is Superior to Mitotic Index and MIB-1 Expression as a Predictor of Recurrence in Human Meningiomas.
Winther TL; Arnli MB; Salvesen Ø; Torp SH
Am J Clin Pathol; 2016 Oct; 146(4):510-20. PubMed ID: 27686177
[TBL] [Abstract][Full Text] [Related]
5. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.
Oya S; Kawai K; Nakatomi H; Saito N
J Neurosurg; 2012 Jul; 117(1):121-8. PubMed ID: 22559847
[TBL] [Abstract][Full Text] [Related]
6. Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.
Duregon E; Cassenti A; Pittaro A; Ventura L; Senetta R; Rudà R; Cassoni P
Neuro Oncol; 2015 May; 17(5):663-9. PubMed ID: 25646026
[TBL] [Abstract][Full Text] [Related]
7. Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.
Olar A; Wani KM; Wilson CD; Zadeh G; DeMonte F; Jones DT; Pfister SM; Sulman EP; Aldape KD
Acta Neuropathol; 2017 Mar; 133(3):431-444. PubMed ID: 28130639
[TBL] [Abstract][Full Text] [Related]
8. Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II.
Prat-Acín R; Guarín-Corredor MJ; Galeano-Senabre I; Ayuso-Sacido A; Vera-Sempere F
J Clin Neurosci; 2021 Apr; 86():32-37. PubMed ID: 33775343
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for patients with World Health Organization grade III meningiomas treated at a single center.
Shan B; Zhang J; Song Y; Xu J
Medicine (Baltimore); 2017 Jun; 96(26):e7385. PubMed ID: 28658170
[TBL] [Abstract][Full Text] [Related]
10. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
[TBL] [Abstract][Full Text] [Related]
11. WHO grade 1 meningioma recurrence: Are location and Simpson grade still relevant?
Gallagher MJ; Jenkinson MD; Brodbelt AR; Mills SJ; Chavredakis E
Clin Neurol Neurosurg; 2016 Feb; 141():117-21. PubMed ID: 26780494
[TBL] [Abstract][Full Text] [Related]
12. Meningiomas: Objective assessment of proliferative indices by immunohistochemistry and automated counting method.
Chavali P; Uppin MS; Uppin SG; Challa S
Neurol India; 2017; 65(6):1345-1349. PubMed ID: 29133712
[TBL] [Abstract][Full Text] [Related]
13. Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primary atypical and malignant meningiomas: a study of 86 patients.
Vranic A; Popovic M; Cör A; Prestor B; Pizem J
Neurosurgery; 2010 Oct; 67(4):1124-32. PubMed ID: 20881577
[TBL] [Abstract][Full Text] [Related]
14. Significance of the Extent of Resection in Modern Neurosurgical Practice of World Health Organization Grade I Meningiomas.
Winther TL; Torp SH
World Neurosurg; 2017 Mar; 99():104-110. PubMed ID: 27867123
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.
Bruna J; Brell M; Ferrer I; Gimenez-Bonafe P; Tortosa A
Neuropathology; 2007 Apr; 27(2):114-20. PubMed ID: 17494511
[TBL] [Abstract][Full Text] [Related]
16. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
[TBL] [Abstract][Full Text] [Related]
17. Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma.
Nanda A; Bir SC; Maiti TK; Konar SK; Missios S; Guthikonda B
J Neurosurg; 2017 Jan; 126(1):201-211. PubMed ID: 27058201
[TBL] [Abstract][Full Text] [Related]
18. The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria.
Ribalta T; McCutcheon IE; Aldape KD; Bruner JM; Fuller GN
Am J Surg Pathol; 2004 Nov; 28(11):1532-6. PubMed ID: 15489659
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas.
Kim YJ; Ketter R; Steudel WI; Feiden W
Am J Clin Pathol; 2007 Jul; 128(1):118-25. PubMed ID: 17580279
[TBL] [Abstract][Full Text] [Related]
20. Pathodiagnostic parameters for meningioma grading.
Moradi A; Semnani V; Djam H; Tajodini A; Zali AR; Ghaemi K; Nikzad N; Madani-Civi M
J Clin Neurosci; 2008 Dec; 15(12):1370-5. PubMed ID: 18819804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]